10x GenomicsTXG +2.85%62 Quick Ratio is 5.42 as of Mar. 2026, which is 16% above its 10-year median of 4.66. GuruFocus rates TXG with a GF Score™ of 62/100 and a GF Value™ of $19.00 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, 10x Genomics ranks better than 90.04% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. 10x Genomics's quick ratio for the quarter that ended in Mar. 2026 was 5.42.
10x Genomics has a quick ratio of 5.42. It generally indicates good short-term financial strength.
The historical rank and industry rank for 10x Genomics's Quick Ratio or its related term are showing as below:
TXG'
s Quick Ratio Range Over the Past 10 Years
Min: 2.2 Med: 4.66 Max: 9.55
Current: 5.42
During the past 9 years, 10x Genomics's highest Quick Ratio was 9.55. The lowest was 2.20. And the median was 4.66.
TXG's Quick Ratio is ranked better than 90.04% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.32
vs TXG: 5.42
10x Genomics (NAS:TXG) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
10x Genomics Quick Ratio Related Terms
10x Genomics Quick Ratio Historical Data
* Premium members only.
The historical data trend for 10x Genomics's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, 10x Genomics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
10x Genomics Quick Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Quick Ratio distribution charts can be found below:
* The bar in red indicates where 10x Genomics's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
10x Genomics's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
10x Genomics (TXG) has a Quick Ratio of 5.42 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on 10x Genomics and its competitors. This is 16% above median its historical median of 4.66. Over the past decade, 10x Genomics' Quick Ratio has ranged from 2.20 to 9.55. According to the industry distribution chart, 10x Genomics ranks #68 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 10%.
Is 10x Genomics' Quick Ratio too high?
10x Genomics' current Quick Ratio of 5.42 is 16% above median its 10-year median of 4.66. Over the past 10 years, this metric has ranged from a low of 2.20 to a high of 9.55. The Healthcare Providers & Services industry median Quick Ratio is 1.32. 10x Genomics' value of 5.42 is 310.6% above this industry median. Based on the distribution chart, 10x Genomics ranks #68 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, 10x Genomics has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Quick Ratio compare to WAY and DOCS?
According to the Healthcare Providers & Services industry distribution chart, 10x Genomics ranks #68 out of 683 companies for Quick Ratio. This places 10x Genomics in the top 10% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.32. 10x Genomics' value of 5.42 is 310.6% above this benchmark. Historically, 10x Genomics' own Quick Ratio has ranged from 2.20 to 9.55 over the past decade. While the company's 10-year median is 4.66 vs. the industry median of 1.32, 10x Genomics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 10x Genomics's current Quick Ratio of 5.42 is 310.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on 10x Genomics and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 10x Genomics's current Quick Ratio is 5.42, which is 16% above median its own 10-year median of 4.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
Based on GuruFocus' analysis, 10x Genomics (TXG) is currently considered Significantly Overvalued. The stock's GF Value™ is $19.00, compared to a current price of $36.70 — trading 93.2% above its estimated fair value. The current Quick Ratio is 5.42, which is 16% above median its 10-year median of 4.66 and 310.6% above the Healthcare Providers & Services industry median of 1.32. 10x Genomics' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For 10x Genomics (TXG), the current Quick Ratio is 5.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 10x Genomics (TXG) Overvalued in 2026?
Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued.
The current stock price of $36.70 is trading 93.2% above its estimated GF Value™ of $19.00.
GuruFocus considers 10x Genomics to be Significantly Overvalued.
Key valuation signals for TXG:
Quick Ratio: 5.42 (16% above median its 10-year median of 4.66)
GF Value™: $19.00 vs. price of $36.70 (93.2% above fair value)
Industry Position: 310.6% above the Healthcare Providers & Services median (#68 of 683)
No single metric tells the full story. See the TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
62GF Score
Get the complete analysis for TXG
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TXG has been successfully added to your 
